Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complementary and alternative therapies.

Barrie R Cassileth1, Andrew J Vickers

  • 1Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. cassileth@mskcc.org

The Urologic Clinics of North America
|May 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.

European urology·2024
Same author

Successful completion of large, low-cost randomized cancer trials at an academic cancer center.

Clinical trials (London, England)·2024
Same author

Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate Cancer.

The Journal of urology·2024
Same author

Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk.

European urology·2024
Same author

Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.

JAMA oncology·2024
Same author

Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.

JNCI cancer spectrum·2024

Patients with prostate cancer are using complementary and alternative therapies. Oncologists should guide patients to use these safely, avoiding them as cancer cures.

Area of Science:

  • Oncology
  • Integrative Medicine

Background:

  • Increasing use of complementary and alternative therapies (CAT) by prostate cancer patients.
  • Need for oncologists to guide patients on safe CAT use.

Purpose of the Study:

  • To inform oncologists about the role of CAT in prostate cancer care.
  • To guide safe integration of beneficial CAT while mitigating risks.

Main Methods:

  • Review of current evidence on CAT for prostate cancer.
  • Discussion of potential benefits and risks of specific botanical medicines (e.g., PC-SPES).

Main Results:

  • Some CAT may help manage symptoms in early-stage prostate cancer.
  • Botanical medicines like PC-SPES show preliminary promise but require further research and quality control.

Related Experiment Videos

  • Alternative therapies should not replace conventional cancer treatment.

    • Conclusions:

    • Oncologists must be knowledgeable about CAT to guide patients effectively.
    • Caution is advised with botanical remedies due to potential adverse effects and drug interactions.
    • Prioritize evidence-based care and patient safety when considering complementary therapies.